CCC
EW icon

Chesapeake Capital Corp’s Edwards Lifesciences EW Stock Holding History

Chesapeake Capital Corp’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.35M Buy
14,920
+1,452
+11% +$122K 0.71% 30
2026
Q1 		$1.08M Buy
13,468
+498
+4% +$41.1K 0.78% 36
2025
Q4 		$1.11M Buy
12,970
+116
+0.9% +$9.52K 0.93% 26
2025
Q3 		$1,000K Buy
+12,854
New +$1M 0.9% 30
2024
Q3 		– Sell
-6,048
Closed -$559K – 185
2024
Q2 		$559K Buy
+6,048
New +$536K 0.73% 34

Other funds holding EW

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
NONA
Ninety One North America New York $2.13B AUM 9.16% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return

Chesapeake Capital Corp's EW Position: Q2 2026 in Review

Chesapeake Capital Corp increased its Edwards Lifesciences (EW) stake by 11% in Q2 2026, buying an estimated $122K and bringing the position to 14,920 shares worth $1.35M. The position accounts for 0.71% of the portfolio, ranked #30.

Chesapeake Capital Corp first reported a position in EW in Q2 2024 and has held it in 5 quarters since. 563 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Chesapeake Capital Corp held 14,920 shares of Edwards Lifesciences worth $1.35M as of Q2 2026.
  • Chesapeake Capital Corp bought 1,452 Edwards Lifesciences shares in Q2 2026, an estimated $122K.
  • Edwards Lifesciences made up 0.71% of Chesapeake Capital Corp's portfolio in Q2 2026, its #30 holding.
  • Chesapeake Capital Corp first reported a position in Edwards Lifesciences in Q2 2024 and has held it in 5 quarters since.
  • 563 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Chesapeake Capital Corp's 13F filing for Q2 2026, filed 29 Jul 2026.